Hosts: Vincent Racaniello and Dickson Despommier On episode 11 of the podcast “This Week in Parasitism”, Vincent and Dickson continue their discussion of malaria, with emphasis on clinical aspects of the disease. [powerpress url=”http://traffic.libsyn.com/twip/TWiP011.mp3″] Click the arrow above to play, or right-click to download TWiP is brought to you by the American Society for Microbiology …
One property of viruses that is difficult to conceptualize is their small size. I can tell you that viruses can be anywhere from 20 to 750 nanometers in diameter, but that’s not easy to visualize, even for those of us who routinely work with small measurements. One way to demonstrate how small viruses are is …
Hosts: Vincent Racaniello, Rich Condit, Dave Bloom, and Grant McFadden On episode #84 of the podcast This Week in Virology, Vincent and Rich spoke with Dave Bloom and Grant McFadden about their work on herpesviruses and poxviruses in this episode recorded before an audience at the University of Florida, Gainesville – home of the Gators. …
A serious shortcoming of current influenza virus vaccines is the need to reformulate them every year or two as the virus undergoes antigenic drift. Many virologists have been captivated by the idea of a more universal vaccine that would endure longer, perhaps a decade or more. The identification of a conserved domain in the stalk …
I joined Marc Pelletier on episode 60 of Futures in Biotech for a conversation with Dave Brodbeck, George Farr, and Andre Nantel. We talked about primate face recognition, discovery of a new antiviral compound to treat hepatitis C virus infection, changing the length of a codon from three to four bases, and the sequence of …
Futures in Biotech 60: Do you come to this cave often? Read More »
Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Kirsten Sanford On episode #83 of the podcast This Week in Virology, Vincent, Alan, Rich, and special guest Dr. Kirsten Sanford talk about her career in science media, then consider whether smallpox eradication led to the AIDS pandemic, high fidelity RNA synthesis, and a new Ebola virus …
